Understanding treatment outcomes in Hispanic patients with inflammatory bowel diseases
Comparative effectiveness research in Hispanic patients with inflammatory bowel diseases
This study looks at how well treatments work for Hispanic patients with inflammatory bowel diseases like Crohn’s and ulcerative colitis, and it aims to understand how social factors and biology affect their health outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11013383 on NIH RePORTER |
What this research studies
This research investigates the treatment outcomes and disease patterns of Hispanic patients suffering from inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis. By utilizing large-scale epidemiologic studies and real-world data, the research aims to identify the social and biological factors that influence health outcomes in this underrepresented population. The study seeks to provide insights into how social determinants of health affect the management and effectiveness of treatments for IBD in Hispanic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic individuals diagnosed with inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.
Not a fit: Patients who do not identify as Hispanic or those without a diagnosis of inflammatory bowel diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better health outcomes for Hispanic patients with inflammatory bowel diseases.
How similar studies have performed: Other research has shown success in understanding treatment outcomes in diverse populations, but this specific focus on Hispanic patients with IBD is relatively novel.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Singh, Siddharth — University of California, San Diego
- Study coordinator: Singh, Siddharth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.